Skip to main content

Antibodies against coronavirus start to decrease in 2 - 3 months , study finds.

Antibodies against coronavirus :

A few countries , including the U.K , were toying with the idea of issuing some form of a certificate to people who have been infected with novel coronavirus and recovered subsequently , as such people were assumed to be resistant to reinfection.
Incidentally this idea was born even before any evidence about how long the antibodies produced in response to infection would last.

Now a study published in Nature Medicine suggests that antibodies formed against SARS- Cov-2 begin to decrease in number , just two-three months after infection. "We observed that IgG levels and neutralizing antibodies in a high proportion of individuals who recovered from SARS - Cov-2 infection starts to decrease within two-three months after infection. "Quan-Xin Long from Chongqing Medical University , Chongqing ,China and others write.


In contrast , circulating antibodies against 2002-2003 SARS and MERS coronavirus were found to last more than one year. In the case of 2002 SARS , sustained IgG levels ere seen for more than two years after infection , while antibody response lasted for nearly three years in case of MERS(Middle East Respiratory Syndrome).

This does not necessarily mean that people previously infected with SARS-Cov-2 can be reinfected soon after. Even if the antibody level decreases , it might be protective . "A person with low antibody level can get reinfected but the viral load will be low , infectivity will be less and he/she may not progress to a disease state says virologist Jacob John formerly with Christian Medical College Vellore. "Antibodies specific to a virus even when present in low levels will be protective against disease".

Besides inducing neutralising antibodies , novel coronavirus has also been found to induce cellular immunity. As a result , the immune system's T cells and B cells are elevated in an infected person.
:Generally , when  antibody levels are high , the T cells are low and vice versa ", says Dr.John.

When infected by a virus , non-specific immune response in the form of macrophages , neutrophils and other cells tend to prevent the virus from causing symptoms. Soon after , the body makes antibodies specific to the virus called the immunoglobulins - IgG and IgM , called the adaptive response. In addition , the cellular immunity kicks in when the body makes T cells that destroy cells that have been infected by the virus. The combination of adaptive response and cellular immunity "may prevent progression to sever illness or re-infection by the same virus. This process is often measured by the presence of antibodies in blood , "WHO says.

For the study , the researchers compared 37 asymptomatic people with an equal number of people who exhibited overt symptoms in the Wanzhou District of China . They found that asymptomatic people were eliciting a weaker immune response to the virus compared with those who developed symptoms.

As a result , 40% of asymptomatic individuals had antibody levels at undetectable levels compared with nearly 13% in the case of asymptomatic individuals. Nearly 80% of people infected with SARS-Cov-2 show  no or very mild symptoms. (by The Hindu)

Comments

Popular posts from this blog

DID PLACEBO EFFECT WORKS?

what is placebo effect? It is a phenomenon in which some people experience a benefit after the administration of inactive substance. A placebo is a fake treatment that in some cases it can produce a realistic result. This depends upon the expectation of the patient,the more a paerson expects the treatment will work, it is more likely to respond. Things that will influence the placebo effect includes                                                                          The nature of illness The belief system of the patient during treatment The expectation of the patient if fulfilling The positive message from the doctor about treatment EFFECT ON HORMONES Taking the placebo tretament triggered the release of endorphins. Endorphins have a similar structure as morphine and other opiate painkillers and act as the brains own natural painkillers. Other possible things include conditioning , motivation and expectation. People who are highly motivated

CAN YOU DIE FROM RHEUMATOID ARTHRITIS(RA)?

WHAT IS RHEUMATOID ARTHRITIS(RA)? Rheumatoid Arthritis(RA) is an autoimmune disease that can cause joint pain and damage throughout your body. It is a chronic disease marked by symptoms of inflammation and pain in the joints. It can also cause inflammation of organs such as the lungs, eyes, skin, and heart. There is no cure for RA, but medications can stop the progression of the disease  and ease symptoms. The  joint damage that RA causes usually happens on both sides of the body. Treatment is possible when RA is diagnosed early. SIGNS AND SYMPTOMS The sign and symptoms of RA come and go, depending upon the degree of inflammation. When the body tissues are inflammed, the disease is active and when the tissue inflammation subsides the disease is inactive. THE SIGN AND SYMPTOMS INCLUDE; Fatigue low grade fever muscle and joint pain joint tenderness joint deformity loss of energy rheumatoid nodules loss of joint function limping stiffness Muscle and joint stiffness are usually seen in the

DID FABIFLU IS THE MEDICINE OF COVID-19 ?

Fabiflu in COVID-19  As we know the vaccine is still a long distance away and no sign of the coronavirus infections slowing down in the country , homegrown pharmaceutical companies have been given permission to launch generic versions of Remdesivir and Favipiravir , anti-viral drugs that have shown promise in treating Covid-19 patients. Glenmark pharmaceuticles has launched favipiravir under the brand name FabiFlu for treatment of mild to moderate cases of Covid-19 , cipla and hetero labs have received approvals from the Drug Controller General of India to launch generic versions of Remedesivir under the names Cipremi and Covifor respectively. While medical experts have cautioned against seeing these potential drugs as a "magic bullet" against the deadly virus , they can be helpful in reducing the viral load as India continues to post new record highs in infection on a daily basis. Remedesivir and Favipiravir are two of the 130 under experimentation drugs worldwide to treat c